(19)

(11)

EP 4 077 632 A1

(12)

(43) Date of publication: 26.10.2022 Bulletin 2022/43 (21) Application number: 20821106.0 (22) Date of filing: 16.12.2020

(51) International Patent Classification (IPC):  C12N 1/04(2006.01) A61K 35/66(2015.01) (52) Cooperative Patent Classification (CPC): C12N 1/04; C12P 1/04 (86) International application number: PCT/EP2020/086456 (87) International publication number: WO 2021/122771 (24.06.2021 Gazette 2021/25)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA ME Designated Validation States: KH MA MD TN (30) Priority: 16.12.2019 EP 19216569 (71) Applicant: 4D Pharma Research Limited Aberdeen, Aberdeenshire AB25 2ZS (GB)	(72) Inventors: DECLOMESNIL, Sophie Leeds LS1 2JZ (GB) CARITE, Christophe Leeds LS1 2JZ (GB) BAKER, Greg John Leeds LS1 2JZ (GB) (74) Representative: Brand Murray Fuller LLP  50 Eastcastle Street London W1W 8EA London W1W 8EA (GB)